Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

Subjects:

Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects:

Cases and age-standardized rates of hematological malignancies in mainland China and their temporal trends. by Yu Fu (16582)

Subjects:

Projections of incidence for hematological malignancies in mainland China. by Yu Fu (16582)

Subjects:

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for lymphoma, multiple myeloma, and other hematological neoplasms in mainland China. by Yu Fu (16582)

Subjects:

Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects:

Cases and age-standardized rates of hematological malignancies in Taiwan and their temporal trends. by Yu Fu (16582)

Subjects:

The raw data used in this study. by Yu Fu (16582)

Subjects:

Age- and sex-specific distribution of prevalence, incidence, mortality, and DALY rates for leukemia in mainland China. by Yu Fu (16582)

Subjects:

Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

Subjects:

Projected global leukemia burden, 1990-2050. by Chengjun Hu (588206)

Subjects:

Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Subjects:

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

The percentage of received patients who migrated for primary knee arthroplasty in different provinces. by Fanqiang Meng (4786071)

Subjects:

Flowchart of analysis. by Fanqiang Meng (4786071)

Subjects: